These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36698902)

  • 21. Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy.
    Natarajan A; Christopher R; Palakuzhiyil SV; Chandra SR
    Mol Genet Metab Rep; 2021 Mar; 26():100720. PubMed ID: 33552912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn Screening for X-Linked Adrenoleukodystrophy.
    Moser AB; Jones RO; Hubbard WC; Tortorelli S; Orsini JJ; Caggana M; Vogel BH; Raymond GV
    Int J Neonatal Screen; 2016 Dec; 2(4):. PubMed ID: 31467997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
    Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
    Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
    Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
    J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines.
    Vogel BH; Bradley SE; Adams DJ; D'Aco K; Erbe RW; Fong C; Iglesias A; Kronn D; Levy P; Morrissey M; Orsini J; Parton P; Pellegrino J; Saavedra-Matiz CA; Shur N; Wasserstein M; Raymond GV; Caggana M
    Mol Genet Metab; 2015 Apr; 114(4):599-603. PubMed ID: 25724074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
    Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
    Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor.
    Barendsen RW; Dijkstra IME; Visser WF; Alders M; Bliek J; Boelen A; Bouva MJ; van der Crabben SN; Elsinghorst E; van Gorp AGM; Heijboer AC; Jansen M; Jaspers YRJ; van Lenthe H; Metgod I; Mooij CF; van der Sluijs EHC; van Trotsenburg ASP; Verschoof-Puite RK; Vaz FM; Waterham HR; Wijburg FA; Engelen M; Dekkers E; Kemp S
    Front Cell Dev Biol; 2020; 8():499. PubMed ID: 32626714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience.
    Burton BK; Hickey R; Hitchins L; Shively V; Ehrhardt J; Ashbaugh L; Peng Y; Basheeruddin K
    Int J Neonatal Screen; 2022 Jan; 8(1):. PubMed ID: 35076462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Changing Face of Adrenoleukodystrophy.
    Zhu J; Eichler F; Biffi A; Duncan CN; Williams DA; Majzoub JA
    Endocr Rev; 2020 Aug; 41(4):577-93. PubMed ID: 32364223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania.
    Priestley JRC; Adang LA; Drewes Williams S; Lichter-Konecki U; Menello C; Engelhardt NM; DiPerna JC; DiBoscio B; Ahrens-Nicklas RC; Edmondson AC; Reynoso Santos FJ; Ficicioglu C
    Int J Neonatal Screen; 2022 Mar; 8(2):. PubMed ID: 35466195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective.
    Prinzi J; Pasquali M; Hobert JA; Palmquist R; Wong KN; Francis S; De Biase I
    Int J Neonatal Screen; 2023 Nov; 9(4):. PubMed ID: 37987477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
    van de Beek MC; Dijkstra IM; van Lenthe H; Ofman R; Goldhaber-Pasillas D; Schauer N; Schackmann M; Engelen-Lee JY; Vaz FM; Kulik W; Wanders RJ; Engelen M; Kemp S
    PLoS One; 2016; 11(4):e0154597. PubMed ID: 27124591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies.
    Ryalls MR; Gan HW; Davison JE
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):212-217. PubMed ID: 32394691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1
    Kettwig M; Klemp H; Nessler S; Streit F; Krätzner R; Rosewich H; Gärtner J
    J Inherit Metab Dis; 2021 Sep; 44(5):1174-1185. PubMed ID: 33855724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
    J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn Screening for X-Linked Adrenoleukodystrophy in Georgia: Experiences from a Pilot Study Screening of 51,081 Newborns.
    Hall PL; Li H; Hagar AF; Jerris SC; Wittenauer A; Wilcox W
    Int J Neonatal Screen; 2020 Oct; 6(4):. PubMed ID: 33239602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening.
    Rajakumar HK; Coimbatore Sathyabal V; Nachiappan R; Krishnaswamy Vijayaramanujam S
    Degener Neurol Neuromuscul Dis; 2024; 14():75-83. PubMed ID: 38912366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked adrenoleukodystrophy and primary adrenal insufficiency.
    Cappa M; Todisco T; Bizzarri C
    Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical spectrum of X-linked adrenoleukodystrophy: from Addison's-only in men to middle-age neurologic manifestations in women.
    Fadiga L; Melo M; Saraiva J; Paiva I
    Hormones (Athens); 2022 Mar; 21(1):33-40. PubMed ID: 34652632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.